The impact of elevated fibrinogen and low albumin levels on survival in cancer patients has been evaluated in several studies based on their roles in reflecting the systemic inflammatory response and nutritional status, both of which are closely associated with cancer progression and patient outcomes [9,10,11,12,13,14,15]. Here, ALB is linked to cancer.